190 related articles for article (PubMed ID: 20567502)
21. Identification of Salivary Proteomic Biomarkers for Oral Cancer Screening.
Ishikawa S; Ishizawa K; Tanaka A; Kimura H; Kitabatake K; Sugano A; Edamatsu K; Ueda S; Iino M
In Vivo; 2021; 35(1):541-547. PubMed ID: 33402507
[TBL] [Abstract][Full Text] [Related]
22. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches.
Heawchaiyaphum C; Pientong C; Phusingha P; Vatanasapt P; Promthet S; Daduang J; Teeramatwanich W; Kongyingyoes B; Chuerduangphui J; Ekalaksananan T
J Proteomics; 2018 Feb; 173():52-61. PubMed ID: 29199150
[TBL] [Abstract][Full Text] [Related]
23. Detection of interleukins-6 and 8 in saliva as potential biomarkers of oral pre-malignant lesion and oral carcinoma: A breakthrough in salivary diagnostics in Pakistan.
Khyani IAM; Qureshi MA; Mirza T; Farooq MU
Pak J Pharm Sci; 2017 May; 30(3):817-823. PubMed ID: 28653927
[TBL] [Abstract][Full Text] [Related]
24. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
Jou YJ; Hua CH; Lin CD; Lai CH; Huang SH; Tsai MH; Kao JY; Lin CW
Clin Chim Acta; 2014 Sep; 436():121-9. PubMed ID: 24863804
[TBL] [Abstract][Full Text] [Related]
25. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I
PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132
[TBL] [Abstract][Full Text] [Related]
26. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
27. Relevance of serum and salivary sialic acid in oral cancer diagnostics.
Guruaribam VD; Sarumathi T
J Cancer Res Ther; 2020; 16(3):401-404. PubMed ID: 32719243
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic value of the native fluorescence visualization device for early detection of premalignant/malignant lesions of the oral cavity.
Amirchaghmaghi M; Mohtasham N; Delavarian Z; Shakeri MT; Hatami M; Mosannen Mozafari P
Photodiagnosis Photodyn Ther; 2018 Mar; 21():19-27. PubMed ID: 29079347
[TBL] [Abstract][Full Text] [Related]
29. Salivary protein markers: a noninvasive protein profile-based method for the early diagnosis of oral premalignancy and malignancy.
Patil A; Choudhari KS; Unnikrishnan VK; Shenoy N; Ongole R; Pai KM; Kartha VB; Chidangil S
J Biomed Opt; 2013 Oct; 18(10):101317. PubMed ID: 23958948
[TBL] [Abstract][Full Text] [Related]
30. A proteomic approach to compare saliva from individuals with and without oral leukoplakia.
Camisasca DR; da Rós Gonçalves L; Soares MR; Sandim V; Nogueira FC; Garcia CH; Santana R; de Oliveira SP; Buexm LA; de Faria PA; Dias FL; Pereira DA; Zingali RB; Alves G; Lourenço SQ
J Proteomics; 2017 Jan; 151():43-52. PubMed ID: 27478070
[TBL] [Abstract][Full Text] [Related]
31. Salivary microRNAs in oral cancer.
Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
[TBL] [Abstract][Full Text] [Related]
32. Salivary transcriptome diagnostics for oral cancer detection.
Li Y; St John MA; Zhou X; Kim Y; Sinha U; Jordan RC; Eisele D; Abemayor E; Elashoff D; Park NH; Wong DT
Clin Cancer Res; 2004 Dec; 10(24):8442-50. PubMed ID: 15623624
[TBL] [Abstract][Full Text] [Related]
33. Assessment of candidate biomarkers in paired saliva and plasma samples from oral cancer patients by targeted mass spectrometry.
Chi LM; Hsiao YC; Chien KY; Chen SF; Chuang YN; Lin SY; Wang WS; Chang IY; Yang C; Chu LJ; Chiang WF; Chien CY; Chang YS; Chang KP; Yu JS
J Proteomics; 2020 Jan; 211():103571. PubMed ID: 31689561
[TBL] [Abstract][Full Text] [Related]
34. Potential protein biomarkers for burning mouth syndrome discovered by quantitative proteomics.
Ji EH; Diep C; Liu T; Li H; Merrill R; Messadi D; Hu S
Mol Pain; 2017 Jan; 13():1744806916686796. PubMed ID: 28326926
[TBL] [Abstract][Full Text] [Related]
35. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
Wang Q; Gao P; Wang X; Duan Y
Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
[TBL] [Abstract][Full Text] [Related]
36. Detection of apoptotic cells in whole saliva of patients with oral premalignant and malignant lesions: a preliminary study.
Cheng B; Rhodus NL; Williams B; Griffin RJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Apr; 97(4):465-70. PubMed ID: 15088030
[TBL] [Abstract][Full Text] [Related]
37. Investigating the level of salivary endothelin-1 in premalignant and malignant lesions.
Nosratzehi T; Risbaf Fakour S; Alijani E; Salehi M
Spec Care Dentist; 2017 May; 37(3):134-139. PubMed ID: 28199027
[TBL] [Abstract][Full Text] [Related]
38. Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy.
Metgud R; Patel S
Biotech Histochem; 2014 Jan; 89(1):8-13. PubMed ID: 23738795
[TBL] [Abstract][Full Text] [Related]
39. Proteomics of saliva, plasma, and salivary gland tissue in Sjögren's syndrome and non-Sjögren patients identify novel biomarker candidates.
Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
J Proteomics; 2020 Aug; 225():103877. PubMed ID: 32540407
[TBL] [Abstract][Full Text] [Related]
40. [Application of saliva protein fingerprints in the diagnosis of oral squamous cell cancer by surface enhanced laser desorption ionization time of flight mass].
Sun G; Ping FY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Nov; 44(11):664-7. PubMed ID: 20079267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
